PEDBASE.org - The Pediatric Database -
Detailed information of FRIEDREICH ATAXIA
FRIEDREICH ATAXIA
DEFINITION:
A multisystem disorder characterized by progressive ataxia and
neurologic, cardiac, musculoskeletal, and endocrine manifestations.
EPIDEMIOLOGY:
- incidence: 1/100,000 live births
- age of onset:
- usually prior to 10 years of age (but as late as 16 years)
- risk factors:
- familial - autosomal recessive
- chrom.#: 9q13-q21.1
- gene: frataxin
- clinical features similar in members of same family
- heterozygotes are phenotypically normal
PATHOGENESIS:
- genetic defect -> impaired expression of frataxin ->
accumulation of iron within the mitochondria of affected cells ->
production of free radicals within the affected cells -> cell
death -> phenotypic expression in the nervous system (CNS and
peripheral nerves), cardiac tissue and pancreas
CLINICAL FEATURES:
- initial presentation in 95% of cases
- slowly progressive -> loss of ambulation within 20 yrs
2. Cerebellar Dysfunction
- dysarthria (explosive)
- dysdiadokokinesia
- finger-nose ataxia
- tend to be more common & severe in the lower limbs than
upper limbs
- head titubation
- ocular dysmetria
- positive Romberg test
3. Others
1. Reflexes
- absent deep tendon reflexes
- extensor plantar reflex
2. Sensation
- loss of vibration and position sense
- impaired light touch and pain sensation
3. Others
- normal intelligence
- neurosensory hearing loss
- muscle weakness in hands and feet
2. Cardiac Manifestations
1. Hypertrophic Cardiomyopathy (in 90% of patients)
- systolic ejection murmer
- SOBOE, palpitations, chest pain (angina)
- arrhythmias, congestive heart failure, death
3. Musculoskeletal Manifestations
- hammer toes
- pes cavus (high-arched feet)
- progressive kyphoscoliosis
4. Endocrine Manifestations
- insulin dependent diabetes mellitus
- onset in 3rd decade in 10-20% of patients
INVESTIGATIONS:
1. Evoked Potentials
- abnormal auditory brainstem, spinal somatosensory, visual
evoked potentials
2. EMG
- slowed nerve conduction velocities in affected limbs
3. ECG
- reduced T wave amplitude, RVH and/or LVH, arrhythmias
4. Imaging Studies
- x-rays to follow musculoskeletal manifestations
5. Serum
- abnormal glucose tolerance test, hyperglycemia
MANAGEMENT:
1. Supportive
- no treatment available to stop progression of disease
- symptomatic treatment of various manifestations
INTERNET LINKS:
National
Ataxia Foundation
Muscular Dystrophy Association (Australia) -
Friedreich's Ataxia
|
Pediatric Database - FRIEDREICH ATAXIA
Pediatric Organization - Pedbase [at] Gmail.com